Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

62.5%

5 terminated/withdrawn out of 8 trials

Success Rate

37.5%

-49.0% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results5 withdrawn

Enrollment Performance

Analytics

Phase 2

3(42.9%)

Phase 3

2(28.6%)

Phase 1

1(14.3%)

Phase 4

1(14.3%)

7Total

Phase 2(3)

Phase 3(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03923322Phase 2Withdrawn

Botanical Tincture for Symptoms of Irritable Bowel Syndrome

Role: lead

NCT01463670Phase 2Completed

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Role: collaborator

NCT05256043Completed

Investigation of Critically Ill Patients With Newly Diagnosed Diabetes

Role: lead

NCT02581501Phase 1Withdrawn

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

Role: lead

NCT02286232Phase 3Completed

Chronic Low Back Pain Randomized Controlled Trial

Role: lead

NCT01592630Phase 3Withdrawn

Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections

Role: lead

NCT00773552Phase 4Withdrawn

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Role: lead

NCT00795106Phase 2Withdrawn

Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain

Role: lead

All 8 trials loaded